Dietary supplement ingredient claims and legal flames – Video

Noncompliant dietary supplement ingredient claims can be one of the reasons the Food and Drug Administration or Federal Trade Commission comes knocking. In this education session and interactive workshop, experts examined ingredient claims, regulators and other challengers, and the doctrine of substantiation. Experts from clinical research organizations also discussed the intricacies of clinical trials and building science to substantiate advertising and marketing claims.

0:00:00-0:06:48 – Introduction  by Josh Long, associate editorial director of SupplySide Supplement Journal

0:06:48-0:09:09 — Opening remarks by moderator Asa Waldstein and first polling question

0:09:09-0:18:55 — Remarks by Katie Bond, Esq., partner of Keller & Heckman LLP, on regulators, other challengers and types of claims

0:18:57-0:29:22 — Presentation by Theodora (“Teddy”) McCormick, Esq., partner with Epstein Becker & Green PC, on the substantiation doctrine and avoiding regulatory perils

0:29:30-1:02:49 — Another polling question by Asa Waldstein and moderator conversation with four experts about legal claims

1:03:18 – 1:17:50 — Remarks by Stephanie Anne-Girard, Ph.D., director of scientific affairs with SGS Nutrasource, on designing effective clinical trials for dietary supplements

Related:NPA lawsuit, amended FDA petition could shape future of NMN in supplements

1:18:07-1:35:18 — Presentation by Corey Hilmas, Ph.D., M.D., chief regulatory officer of KGK Science Inc., on the p value, sample size considerations, clinical effect and safety.

1:35:20 – 2:03:17 — Polling question by Asa Waldstein and moderator conversation with experts about clinical trials and substantiation

Price: $75